BGI Genomics Co., Ltd. (SHE: 300676)

BGI Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4,468	4,732	5,160	6,590	5,430	735.33
Short-Term Investments	-	-	11.2	6.57	-	-
Trading Asset Securities	475.85	753.58	1,232	2,049	-	482.22
Cash & Short-Term Investments	4,943	5,486	6,403	8,646	5,430	1,218
Cash Growth	-15.12%	-14.32%	-25.94%	59.22%	345.98%	13.78%
Accounts Receivable	1,753	1,464	2,223	1,244	1,576	1,232
Other Receivables	54.84	54.22	174.47	49.74	117.01	103.23
Receivables	1,808	1,518	2,397	1,294	1,693	1,336
Inventory	604.19	602.18	717.83	877.72	1,010	342.97
Other Current Assets	325.07	326.77	257.24	217.2	284.31	307.33
Total Current Assets	7,681	7,933	9,775	11,035	8,417	3,204
Property, Plant & Equipment	3,200	3,190	2,191	1,400	1,287	1,311
Long-Term Investments	1,216	1,252	1,328	898.21	449.29	613.09
Goodwill	47.11	47.11	47.11	47.11	47.11	47.11
Other Intangible Assets	422.45	418.82	410.89	245.46	146.76	161.43
Long-Term Deferred Tax Assets	262.73	241.58	236.29	200.29	162.06	93.54
Long-Term Deferred Charges	356.78	362.86	209.51	177.65	95.89	89.06
Other Long-Term Assets	194.48	167.17	187.25	250.86	589.6	390.8
Total Assets	13,381	13,613	14,385	14,254	11,195	5,909
Accounts Payable	959.17	864.6	1,025	805.32	873.23	221.16
Accrued Expenses	583.28	668.29	958.97	653.08	963.13	267.16
Short-Term Debt	2.36	-	-	5.01	563.3	-
Current Portion of Long-Term Debt	30.95	24.18	-	35.74	23.7	-
Current Portion of Leases	49.91	57.79	63.33	90.6	-	-
Current Income Taxes Payable	40.97	59.79	77.35	167.83	147.02	54.77
Current Unearned Revenue	625.77	699.71	929.35	1,410	840.88	-
Other Current Liabilities	513.39	922.68	901.93	216.41	390.86	591.41
Total Current Liabilities	2,806	3,297	3,956	3,384	3,802	1,134
Long-Term Debt	306.18	215.68	-	631.96	658	-
Long-Term Leases	56.37	67.75	136.68	84.44	73.89	65.83
Long-Term Unearned Revenue	15.05	15.39	19.68	36.07	49.1	46.02
Long-Term Deferred Tax Liabilities	12.58	13.13	51.56	5.19	1.48	26.17
Other Long-Term Liabilities	-	-	-	671.57	584.7	235.56
Total Liabilities	3,196	3,609	4,164	4,813	5,169	1,508
Common Stock	415.82	413.91	413.91	413.91	400.1	400.1
Additional Paid-In Capital	4,721	4,592	4,680	4,657	2,605	2,808
Retained Earnings	4,844	4,826	5,147	4,488	3,160	1,056
Treasury Stock	-99.92	-115.32	-336.75	-87.95	-175.89	-
Comprensive Income & Other	158.25	143.11	172	-152.57	-78.61	49.98
Total Common Equity	10,039	9,859	10,076	9,318	5,910	4,314
Minority Interest	145.98	144.78	145.09	122.87	115.64	86.99
Shareholders' Equity	10,185	10,004	10,221	9,441	6,026	4,401
Total Liabilities & Equity	13,381	13,613	14,385	14,254	11,195	5,909
Total Debt	445.78	365.4	200.01	847.75	1,319	65.83
Net Cash (Debt)	4,498	5,121	6,203	7,798	4,111	1,152
Net Cash Growth	-18.21%	-17.45%	-20.46%	89.68%	256.96%	7.63%
Net Cash Per Share	10.78	12.42	15.12	18.94	10.30	2.88
Filing Date Shares Outstanding	431.31	379.44	409.91	409.91	396.09	400.1
Total Common Shares Outstanding	431.31	379.44	409.91	409.91	396.09	400.1
Working Capital	4,875	4,636	5,819	7,651	4,615	2,069
Book Value Per Share	23.28	25.98	24.58	22.73	14.92	10.78
Tangible Book Value	9,570	9,393	9,618	9,026	5,716	4,106
Tangible Book Value Per Share	22.19	24.76	23.46	22.02	14.43	10.26
Buildings	1,788	1,787	490.05	418.81	422.23	338.11
Machinery	2,333	2,195	1,841	1,612	1,635	1,401
Construction In Progress	472.48	418.08	752.33	38.5	53.4	184.54

Source: S&P Capital IQ. Standard template. Financial Sources.